| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 5,109,900,000 | 3,343,800,000 | 1,613,700,000 | - |
| Cost of sales, adjusted | 3,159,500,000 | 2,061,900,000 | 1,002,300,000 | - |
| Marketing expense | 171,600,000 | 116,700,000 | 44,300,000 | - |
| Selling expense, adjusted | 344,100,000 | 223,100,000 | 105,900,000 | - |
| General and administrative expense, adjusted | 322,000,000 | 233,900,000 | 119,600,000 | - |
| Other segment expense | 243,900,000 | 152,500,000 | 59,900,000 | - |
| Depreciation and amortization | 437,000,000 | 273,900,000 | 128,600,000 | - |
| Interest and financing expense, net | 247,100,000 | 164,000,000 | 82,100,000 | - |
| Loss on modification and extinguishment of debt | -18,600,000 | -18,600,000 | -18,600,000 | - |
| Income taxes | 60,400,000 | 34,000,000 | 17,700,000 | - |
| Net income from continuing operations | 105,700,000 | 65,200,000 | 34,700,000 | - |
| Depreciation and amortization | 437,000,000 | 273,900,000 | 128,600,000 | - |
| Amortization of debt discount and issuance costs | 21,900,000 | 13,700,000 | 6,100,000 | - |
| Stock-based compensation costs | 36,800,000 | 24,900,000 | 12,000,000 | - |
| Restructuring charges | 6,000,000 | 2,900,000 | 500,000 | - |
| Inventory obsolescence expense | 11,800,000 | 7,200,000 | 1,200,000 | - |
| Charge for expected credit losses | 30,100,000 | 17,400,000 | 7,100,000 | - |
| Deferred income taxes | 5,700,000 | -800,000 | -2,600,000 | - |
| Other non-cash items | 19,600,000 | 14,900,000 | -1,500,000 | - |
| Trade receivables | 133,400,000 | 159,000,000 | 67,100,000 | - |
| Inventories | 40,300,000 | 49,100,000 | 45,700,000 | - |
| Prepaid expenses and other current and non-current assets | -21,300,000 | 300,000 | -34,600,000 | - |
| Trade payables | - | - | 13,900,000 | - |
| Accruals and other current and non-current liabilities | - | - | -86,000,000 | - |
| Trade payables and accruals and other current and non-current liabilities | -5,800,000 | 12,700,000 | - | - |
| Net cash provided by operating activities of continuing operations | 477,200,000 | 193,800,000 | 38,800,000 | - |
| Purchases of property, plant and equipment | 231,600,000 | 115,900,000 | 62,000,000 | - |
| Purchases of intangible assets | 42,200,000 | 25,200,000 | 7,500,000 | - |
| Acquisitions, net of cash received | 29,000,000 | 5,700,000 | - | - |
| Proceeds from sale of other assets | 56,900,000 | 56,900,000 | 45,600,000 | - |
| Proceeds from settlement of split-dollar life insurance contracts | - | - | 0 | - |
| Proceeds from insurance settlements | 20,000,000 | - | - | - |
| Other investing activities | -8,000,000 | -16,100,000 | -700,000 | - |
| Net cash used in investing activities of continuing operations | -217,900,000 | -73,800,000 | -23,200,000 | - |
| Proceeds from 2024 incremental term loan, net of discount | 0 | 0 | 0 | - |
| Proceeds from borrowings from abl credit facility | 0 | 0 | 0 | - |
| Repayment of borrowings from abl credit facility | 0 | 0 | - | - |
| Repayment of term loans | 23,200,000 | 15,500,000 | 7,700,000 | - |
| Proceeds from borrowings of other debt | 0 | 0 | 0 | - |
| Principal repayment of other debt | 4,100,000 | 2,700,000 | 1,300,000 | - |
| Principal payment of finance leases | 24,700,000 | 15,800,000 | 7,200,000 | - |
| Financing fees | 7,700,000 | 7,700,000 | 7,500,000 | - |
| Issuance of common stock | 7,700,000 | 4,800,000 | 1,200,000 | - |
| Common stock repurchased and cancelled | 296,800,000 | 221,000,000 | 119,200,000 | - |
| Dividends paid to common stockholders | 113,200,000 | 76,000,000 | 38,600,000 | - |
| Dividends paid to sponsor stockholder | 0 | 0 | 0 | - |
| Other financing activities | -1,000,000 | -900,000 | -500,000 | - |
| Net cash used in financing activities of continuing operations | -463,000,000 | -334,800,000 | -180,800,000 | - |
| Net loss | - | - | - | -2,000 |
| Net cash provided by operating activities from discontinued operations | 8,800,000 | 2,300,000 | 2,900,000 | - |
| Related party accruals-Related Party | - | - | - | 2,000 |
| Net cash used in investing activities from discontinued operations | -1,800,000 | -1,300,000 | -8,000,000 | - |
| Net cash provided by operating activities | - | - | - | 0 |
| Net cash used in by financing activities from discontinued operations | -1,900,000 | 3,400,000 | 2,400,000 | - |
| Net cash provided by investing activities | - | - | - | 0 |
| Net cash provided by discontinuing operations | 5,100,000 | 4,400,000 | -2,700,000 | - |
| Net cash provided by financing activities | - | - | - | 0 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 1,500,000 | 2,100,000 | 500,000 | - |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -197,100,000 | -208,300,000 | -167,400,000 | 0 |
| Cash and cash equivalents at beginning of period | 620,700,000 | 620,700,000 | 620,700,000 | - |
| Cash and cash equivalents at end of period | 423,600,000 | 412,400,000 | 453,300,000 | - |
Primo Brands Corp (PRMB)
Primo Brands Corp (PRMB)